Orofino Gold Corp. (ORFG)

Gold mining companies invest as much as 4.5 billion U.S. dollars over the next ten years in Colombia, attracted by rich unexplored and soaring prices, Arturo Quiros, the head of the country’s miners Asomineros group said on the sidelines of a seminar on mining in capital Bogota.
Colombia is set to attract 4.5 billion dollars of FDI in 2010-2020 in gold, the gold companies to invest 400 million dollars in 2010, Companies producing 3 million ounces of gold in 2015.

Orofino Gold Corp. has several Gold development properties in Colombia, a current hot spot of gold production in the world markets. Orofino Gold Corp. is a Colombia based gold producer founded as a private company in 2009 by former executives with over 50 cumulative years in mining exploration, finance, and development expertise. Orofino’s corporate objective is to continue to build shareholder value through the exploration and development of Senderos de Oro and additional accretive acquisitions, capitalizing on the extensive experience and relationships that management has developed over the past 25 years.

Orofino Gold Corp. (ORFG) recently announced that the appointment of Mr. Salvador Rivero to the company’s Board of Directors. Mr. Rivero brings to Orofino a wealth of knowledge in the areas of business, corporate finance, and mining operations. After graduating from law school in Mexico, Mr. Rivero spent the next 25 years developing a thorough understanding of the processes necessary to successfully discover, acquire, and develop, mineral concessions with the potential of containing valuable mineral deposits. Considered by Orofino as an acquisitions specialist, Mr. Rivero has been involved in the development of various turn-key projects in mining, energy, fertilizer, oil and gas, and shipping sectors.

For more information please visit the official website of ORFG: http://www.orofinogoldcorp.com/

***************************************************************************************************

Power 3 Medical Products Inc. (PWRM)

Parkinson’s disease is a disorder that affects nerve cells, or neurons, in a part of the brain that controls muscle movement. In Parkinson’s, neurons that make a chemical called dopamine die or do not work properly. Dopamine normally sends signals that help coordinate their movements. No one knows what damages these cells. Parkinson’s usually begins around age 60, but it can start earlier. It is more common in men than in women. There is no cure for Parkinson’s disease. A variety of medicines sometimes help symptoms dramatically.

Power3 Medical Products, Inc. is a leading bio-technology company focused on the development of innovative diagnostic tests in the fields of cancer and neurodegenerative diseases such as Alzheimer’s disease, Parkinson’s disease and amyotrophic lateral sclerosis (commonly known as ALS or Lou Gehrig’s disease). Power3 applies proprietary methodologies to discover and identify protein biomarkers associated with diseases.

The NuroPro Blood Test is Power3’s diagnostic tool for the early detection of Neurodegenerative diseases. The analysis is designed as a tool for physicians to diagnose various degenerative diseases of the brain and nervous system. The test involves monitoring the concentration of 59 proteins in blood serum to accurately detect and distinguish between Alzheimer’s disease, ALS (Lou Gehrig’s disease), and Parkinson’s disease . Early detection of these diseases will allow physicians to intervene at an early stage to delay disease progression, potentially allowing patients to outlive their debilitating symptoms.

For more information about Power3 Medical Products, Inc. visit its website http://www.power3medical.com.

**************************************

Global Ship Lease, Inc. (NYSE:GSL) announced its unaudited results for the three months ended December 31, 2010. Reported revenue of $40.0 million for the fourth quarter of 2010, up slightly on $39.9 million for the fourth quarter 2009 due to 16 days offhire in fourth quarter 2009 for a planned drydocking. Revenue for the year ended December 31, 2010 was $158.8 million, up 7% on $148.7 million for the year ended December 31, 2009 due to the full year effect of our seventeenth vessel purchased in August 2009 and better utilization from lower offhire. Reported net income of $1.2 million for the fourth quarter of 2010, including an $11.7 million non-cash interest rate derivative mark-to-market gain and $17.1 million impairment charge. Reported net income for the fourth quarter 2009 was $12.3 million, including $5.1 million non-cash mark-to-market gain. The net loss for the year ended December 31, 2010 was $4.0 million including $15.3 million non-cash interest rate derivative mark-to-market loss and $17.1 million impairment charge compared to net income of $42.4 million for the year ended December 31, 2009 including $17.9 million non-cash interest rate derivative mark-to-market gain and $2.2 million accelerated write off of deferred financing costs.

Global Ship Lease, Inc. engages in owning and chartering out containerships under long term time charters. As of September 30, 2010, the company’s fleet consisted of 17 containerships with an aggregate capacity of 66,297 twenty-foot equivalent unit and a weighted average age of approximately 6.6 years.

********************************

Federal Signal Corp. (NYSE:FSS) announced that its Bronto Skylift Oy Ab (”Bronto”) subsidiary has entered into exclusive supply and distribution agreements with Pierce Manufacturing Inc. (”Pierce”), a wholly-owned subsidiary of Oshkosh Corporation (NYSE:OSK). Under the terms of the agreements, Bronto will become Pierce’s sole source of articulated aerial platform booms for firefighting applications in the North American market, and those devices will be distributed exclusively through Pierce’s network of independent dealers.

Federal Signal Corporation designs and manufactures a suite of products and integrated solutions for municipal, governmental, industrial, and commercial customers worldwide.

********************************

Alliance Healthcare Services, Inc. (NYSE:AIQ) announced results for the fourth quarter and year ended December 31, 2010. Revenue for the fourth quarter of 2010 was $117.7 million compared to $119.5 million in the fourth quarter of 2009. For full year 2010, revenue was $478.9 million, which was within the Company’s guidance range of $470 million to $500 million. Full year 2009 revenue was $505.5 million. Alliance’s Adjusted EBITDA (as defined below) was $35.0 million in the fourth quarter of 2010 compared to $38.2 million in the fourth quarter of 2009. For full year 2010, Adjusted EBITDA totaled $158.1 million, which was within the Company’s guidance range of $155 million to $180 million. Full year 2009 Adjusted EBITDA was $180.3 million. Alliance’s net loss, computed in accordance with GAAP, totaled ($29.6) million in the fourth quarter of 2010 and ($11.0) million in the fourth quarter of 2009. Full year 2010 net loss totaled ($32.7) million compared to net income of $0.5 million for full year 2009. Net loss per share on a diluted basis, computed in accordance with generally accepted accounting principles (”GAAP”), was ($0.56) per share in the fourth quarter of 2010 and ($0.21) per share in the fourth quarter of 2009.

Alliance HealthCare Services, Inc., together with its subsidiaries, provides outpatient diagnostic imaging services and radiation oncology services in the United States.

__

**************************************************************

**************************************************************************

THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY!

Disclaimer: Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. DrStockPick.com publisher and its affiliates and contractors are not registered investment advisers or broker/dealers. Our disclaimer is to be read and fully understood before using our site, reading our newsletter or joining our email list. Release of Liability: Through use of this website viewing or using, you agree to hold DrStockPick.com report and Crown Equity Holdings Inc. CRWE, its operators, shareholders, employees and/or contractors harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damages (monetary or otherwise) that you may occur. (Read more at http://drstockpick.com/disclaimer) .Rule 17B requires disclosure of payment for investor relations. Crown Equity Holdings, Inc. (CRWE.OB) is a newswire as well as an IR and PR firm. Crown Equity Holdings Inc. (CRWE.OB), in some cases, provides media advertising and public awareness for both public and private companies, as well as disseminating news. As such, in some cases, when Crown Equity Holdings Inc. (CRWE.OB) advertises for a particular client, Crown Equity Holdings Inc. (CRWE.OB) charges an advertising fee which it must disclose under 17B. The fee may be in cash, in free trading stock or in restricted stock. Crown Equity Holdings Inc. (CRWE.OB), if paid in stock, can and may sell those securities during the advertising period.Crown Equity Holdings Inc. (CRWE.OB) has received 1,000,000 shares 144 restricted stocks for IT department services and 2,000,000 shares (free trade) for 12 months of video production from Power 3 Medical Products Inc. (PWRM.OB). Crown Equity Holdings Inc. (CRWE.OB) has received 500,000 shares of 144 stock in Orofino Gold Corp. (PINK SHEETS: ORFG) valued at sixty five thousand dollars, and 500,000 shares of free trading shares valued at sixty five thousand dollars from a third party (QU CUI You) for 30 days advertising.

Orofino Gold Corp. (ORFG)

Gold has been found in Northeastern Colombia dating back thousands of years to the years 1 to 1000 A.D. from the Tairona Culture, Early Zenu Culture and the Muisica Culture. The important gold mining center of Buriticá, in the mountains of Colombia’s northern Antioquia Province, exploits rich alluvial deposits and vein gold. Gold objects and raw gold are traded for food, salt, emeralds, and other items with peoples in the north, east, and south.

550 A.D. Full-time goldsmiths in Colombia’s Sinú River area produce impressive ornaments for the chiefs of their Greater Zenú territory. Typical forms are large, hammered, crescent-shaped breast shields with repoussé decoration, and heavy cast staff finials worked in three-dimensional shapes of local fauna, particularly birds.

Orofino Gold Corp. has several Gold development properties in Colombia, a current hot spot of gold production in the world markets. Orofino Gold is a Colombia based gold producer founded as a private company in 2009 by former executives with over 50 cumulative years in mining exploration, finance, and development expertise. Orofino’s corporate objective is to continue to build shareholder value through the exploration and development of Senderos de Oro and additional accretive acquisitions, capitalizing on the extensive experience and relationships that management has developed over the past 25 years.

Orofino Gold Corp. (ORFG) recently announced that an expanding involvement of renown academic Dr. Hans J. Bocker as Orofino continues to increase its activities in preparation for major development on its Colombian mining concessions. Dr. Hans J. Bocker is an internationally recognized academic advisor. His expertise encompasses fundamental organizational and operational logistics including production and operations management, purchasing and procurement, safety, loss control, quality management, international management, cross-cultural management, transportation and traffic logistics, and leadership training for executives. In addition to his logistical expertise, Dr. Bocker is also an internationally recognized Gold expert.

For more information please visit the official website of ORFG: http://www.orofinogoldcorp.com/

********************************************************************************************

Power 3 Medical Products Inc. (PWRM)

Alzheimer’s disease is the most common form of dementia, a group of disorders that impairs mental functioning. Dementia literally means loss of mentation, or thinking. At the moment, Alzheimer’s is progressive and irreversible. Abnormal changes in the brain worsen over time, eventually interfering with many aspects of brain function. Memory loss is one of the earliest symptoms, along with a gradual decline of other intellectual and thinking abilities, called cognitive functions, and changes in personality or behavior. Alzheimer’s advances in stages, progressing from mild forgetfulness and cognitive impairment to widespread loss of mental abilities. In advanced Alzheimer’s, people become dependent on others for every aspect of their care.

Power3 Medical Products, Inc. is a leading bio-technology company focused on the development of innovative diagnostic tests in the fields of cancer and neurodegenerative diseases such as Alzheimer’s disease, Parkinson’s disease and amyotrophic lateral sclerosis (commonly known as ALS or Lou Gehrig’s disease). Power3 Medical applies proprietary methodologies to discover and identify protein biomarkers associated with diseases. Through these processes, Power3 Medical has developed a portfolio of products including BC-SeraPro™, a proteomic blood serum test for the early detection of breast cancer for which it has completed Phase I clinical trials, and NuroPro®, a proteomic blood serum test for the detection of neurodegenerative diseases, including Alzheimer’s, Parkinson’s, and ALS diseases, for which it is currently engaged in Phase II clinical trials.

On average, Alzheimer’s patients live from 8 to 10 years after they are diagnosed, though the disease can last for as many as 20 years. No treatment can stop Alzheimer’s disease, however a number of treatments slow the progression and ease the symptoms. Some medicines may help control behavioral symptoms of Alzheimer’s such as sleeplessness, agitation, wandering, anxiety, and depression. Treating these symptoms often makes patients more comfortable and makes their care easier for caregivers.

For more information about Power3 Medical Products, Inc. visit its website http://www.power3medical.com.

*********************************************

Templeton Global Income Fund, Inc. (NYSE:GIM) announced its regular monthly dividend from net investment income of $0.045 per share, payable on March 31, 2011, to shareholders of record on March 17, 2011 (Ex-Dividend Date: March 15, 2011).

Templeton Global Income Fund is a closed ended fixed income mutual fund launched by Franklin Resources Inc. It is managed by Franklin Advisers Inc. The fund invests in the fixed income markets across the globe.

***********************************

Douglas Dynamics, Inc. (NYSE:PLOW) announced financial results for the fourth quarter and full year ended December 31, 2010. Fourth Quarter Earnings per Diluted Share of $0.23, Full Year Adjusted EBITDA of $47.3 million, an increase of 4.8% versus 2009 and Declares special dividend of $0.37 per share in addition to regular quarterly dividends.

Douglas Dynamics, Inc. engages in the design, manufacture, and sale of snow and ice control equipment for light trucks, which consists of snowplows and sand and salt spreaders, and related parts and accessories in the United States and Canada.

***********************************

KAR Auction Services, Inc. (NYSE:KAR) announced its participation in the following investor conference which will also be available via live audio webcast: Barclays 2011 High Yield Bond and Syndicated Loan Conference, Eric Loughmiller, Chief Financial Officer and Executive Vice will speak on Thursday, March 24th at 11:30 am EDT. Webcast of the presentation will be made available under the investor relations section of the company’s web site, www.karauctionservices.com.

KAR Auction Services, Inc., through its subsidiaries, provides vehicle auction services in North America. It operates in three segments: ADESA Auctions, IAAI, and AFC. The ADESA Auctions encompasses wholesale auctions relates to used vehicle remarketing, including auction services, remarketing, or make ready services.

__

**************************************************************

**************************************************************************

THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY!

Disclaimer: Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. DrStockPick.com publisher and its affiliates and contractors are not registered investment advisers or broker/dealers. Our disclaimer is to be read and fully understood before using our site, reading our newsletter or joining our email list. Release of Liability: Through use of this website viewing or using, you agree to hold DrStockPick.com report and Crown Equity Holdings Inc. CRWE, its operators, shareholders, employees and/or contractors harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damages (monetary or otherwise) that you may occur. (Read more at http://drstockpick.com/disclaimer) .Rule 17B requires disclosure of payment for investor relations. Crown Equity Holdings, Inc. (CRWE.OB) is a newswire as well as an IR and PR firm. Crown Equity Holdings Inc. (CRWE.OB), in some cases, provides media advertising and public awareness for both public and private companies, as well as disseminating news. As such, in some cases, when Crown Equity Holdings Inc. (CRWE.OB) advertises for a particular client, Crown Equity Holdings Inc. (CRWE.OB) charges an advertising fee which it must disclose under 17B. The fee may be in cash, in free trading stock or in restricted stock. Crown Equity Holdings Inc. (CRWE.OB), if paid in stock, can and may sell those securities during the advertising period. Crown Equity Holdings Inc. (CRWE.OB) has received 1,000,000 shares 144 restricted stocks for IT department services and 2,000,000 shares (free trade) for 12 months of video production from Power 3 Medical Products Inc. (PWRM.OB).

Crown Equity Holdings Inc. (CRWE.OB) has received 500,000 shares of 144 stock in Orofino Gold Corp. (PINK SHEETS: ORFG) valued at sixty five thousand dollars, and 500,000 shares of free trading shares valued at sixty five thousand dollars from a third party (QU CUI You) for 30 days advertising.

Proper Power & Energy, Inc. (PPWE)
Oil and natural gas drilling and exploring has been taken up in the Kentucky area of America. Most of the farmers and business people in this area are very well engaged in this business of filling up their treasury with the oil and natural gas reserves within this region. This is after the recent study that has shown that the Kentucky region has got many huge reserves of oil and natural gas. On the back of these studies made by the US geological department most of the farmers of this region who find a hard living by means of farming, are turning to this very lucrative business of oil and natural gas exploration in their respective areas.

Proper Power & Energy is an independent exploration and production company. The Company’s operations are in Kentucky, which provides for low risk developmental drilling and production, and Utah, where the Company controls over 11,000 acres for its exploratory prospect. Renowned geophysicist and consultant to Proper Power, Robert Dunbar, believes the Utah prospect could hold up to one billion barrels of recoverable oil.

Proper Power & Energy, Inc. (PPWE) recently announced that it has been approached by two independent financing groups and has submitted a $10 million private placement memorandum to each of them.
These two groups are seeking domestic oil and gas production in light of the Middle East tensions. The company believes that the timing to acquire oil and gas properties while gas prices are low couldn’t be better. Additionally, the availability of this funding for developing Proper Power’s Kentucky and Utah oil prospects would accelerate 2011 revenues and leasehold acreage growth dramatically.

To learn more about Proper Power & Energy, Inc., Please visit website: www.properpower.com.

*****************************************************************************

Power 3 Medical Products Inc. (PWRM)

Protein has a large number of important functions in the human body and in fact, the human body is about 45% protein. It’s an essential macromolecule without which one’s body would be unable to repair, regulate, or protect themselves. Proteins are, in effect, the main actioners in cells and in an entire organism. Without proteins the most basic functions of life could not be carried out. Respiration, for example, requires muscle contractions, and muscle contractions require proteins.

Power3 Medical Products, Inc. is a leading bio-technology company focused on the development of innovative diagnostic tests in the fields of cancer and neurodegenerative diseases such as Alzheimer’s disease, Parkinson’s disease and amyotrophic lateral sclerosis commonly known as ALS or Lou Gehrig’s disease. Power3 Medical applies proprietary methodologies to discover and identify protein biomarkers associated with diseases. Through these processes, Power3 has developed a portfolio of products including BC-SeraPro™, a proteomic blood serum test for the early detection of breast cancer for which it has completed Phase I clinical trials, and NuroPro®, a proteomic blood serum test for the detection of neurodegenerative diseases.

Proteomics is the global study of protein expression, regulation, modification, and function in living systems for understanding how living systems use proteins. Using a variety of techniques, proteomics can be used to study how protein interacts within a biological system or how proteins change in response to a certain stress conditions. Proteomics require the use of advanced measurement techniques with emphasis on separation and mass spectroscopy.

For more information, please visit http://www.power3medical.com

*******************************

Alon Holdings Blue Square - Israel Ltd (NYSE:BSI) announced that its indirect majority owned subsidiary, Alon Cellular Ltd. (”Alon Cellular”), was informed by the Israeli Ministry of Communications that it had received a mobile virtual network operator license (MVNO license). The MVNO license will enable Alon Cellular to enter the Israeli communication market and add cellular services to the Company’s widespread service offerings, thus providing its customers and YOU loyalty club members with full array of products in the Food (Mega Supermarkets), Fuel (”Dor Alon”) and Non-Food (”Bee Group”).

Alon Holdings Blue Square - Israel Ltd., together with its subsidiaries, operates supermarkets and retail outlets in Israel. It offers food and beverages products; non-food items, such as houseware products, toys, small electrical appliances, computers and computer accessories, entertainment and leisure products, and textile products; and near-food products comprising health and beauty aids, baby and young children products, cosmetics, and hygiene products.

*******************************

KEMET Corp (NYSE:KEM), a leading manufacturer of tantalum, ceramic, aluminum, film, paper and electrolytic capacitors, announced that its operations have not been affected following Friday’s magnitude 8.9 earthquake and resulting tsunami that left towns and villages in Japan devastated.

KEMET Corporation, together with its subsidiaries, manufactures and sells capacitors worldwide. The company offers tantalum, multilayer ceramic, solid and electrolytic aluminum, film, and paper capacitors.

*******************************

Capstead Mortgage Corp. (NYSE:CMO) announced that it will pay a first quarter 2011 dividend of $0.41 per common share on April 20, 2011 to stockholders of record as of March 31, 2011.

Capstead Mortgage Corporation operates as a self-managed real estate investment trust. The company, together with its subsidiaries, invests in a leveraged portfolio of residential mortgage pass-through securities consisting of adjustable-rate mortgage securities issued and guaranteed by government-sponsored enterprises.

__

**************************************************************

**************************************************************************

THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY!

Disclaimer: Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. DrStockPick.com publisher and its affiliates and contractors are not registered investment advisers or broker/dealers. Our disclaimer is to be read and fully understood before using our site, reading our newsletter or joining our email list. Release of Liability: Through use of this website viewing or using, you agree to hold DrStockPick.com report and Crown Equity Holdings Inc. CRWE, its operators, shareholders, employees and/or contractors harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damages (monetary or otherwise) that you may occur. (Read more at http://drstockpick.com/disclaimer) .Rule 17B requires disclosure of payment for investor relations. Crown Equity Holdings, Inc. (CRWE.OB) is a newswire as well as an IR and PR firm. Crown Equity Holdings Inc. (CRWE.OB), in some cases, provides media advertising and public awareness for both public and private companies, as well as disseminating news. As such, in some cases, when Crown Equity Holdings Inc. (CRWE.OB) advertises for a particular client, Crown Equity Holdings Inc. (CRWE.OB) charges an advertising fee which it must disclose under 17B. The fee may be in cash, in free trading stock or in restricted stock. Crown Equity Holdings Inc. (CRWE.OB), if paid in stock, can and may sell those securities during the advertising period.Crown Equity Holdings Inc. (CRWE.OB) received 1,000,000 shares of free trading shares from a third party (Mohamad Nehmeh) for two (2) weeks of advertisement services for Proper Power & Energy, Inc. (PPWE.PK). Crown Equity Holdings Inc. (CRWE.OB) has received 1,000,000 shares 144 restricted stocks for IT department services and 2,000,000 shares (free trade) for 12 months of video production from Power 3 Medical Products Inc. (PWRM.OB).

Eline Entertainment Group, Inc. (PINK SHEETS:EEGI) and the company’s subsidiary Let The Good Times Roll has successfully merged with Midnight Express. This is a second expansion merger for the company.

This is EEGI’s third merger announcement in the last several days, and a second merger for the LTGTR. EEGI management is excited by the speed with which the LTGTR moves, and intends to keep shareholders updated with further details on the progression of any upcoming mergers and already completed mergers.

************************************

Power3 Medical Products, Inc. (OTC.BB:PWRM) a leading proteomics company focused on the development of innovative diagnostic tests in the fields of cancer and neurodegenerative diseases, announced recently that it has signed a definitive agreement to acquire all of the stock of Rozetta-Cell Life Sciences, Inc. Power3 plans to effectuate the acquisition of Rozetta-Cell by merging Rozetta-Cell with and into Power3, with Power3 remaining as the surviving company in the merger.

Power3 Medical Products, Inc. is a leading bio-technology company focused on the development of innovative diagnostic tests in the fields of cancer and neurodegenerative diseases such as Alzheimer’s disease, Parkinson’s disease and amyotrophic lateral sclerosis (commonly known as ALS or Lou Gehrig’s disease). Power3 applies proprietary methodologies to discover and identify protein biomarkers associated with diseases.

************************************

Alliance Data Systems Corporation (NYSE:ADS) announced recently it has signed a long-term agreement with American Laser Centers to provide private label credit services designed to drive sales and enhance long-term customer loyalty.

Alliance Data Systems Corporation (ADSC) is a provider of data-driven and transaction-based marketing and customer loyalty solutions. It offers a portfolio of integrated outsourced marketing solutions.

************************************

Monsanto Company (NYSE:MON) announced recently the open call for applications for students interested in pursuing research in wheat or rice plant breeding. Applications for the third round of funding from Monsanto’s Beachell-Borlaug International Scholars Program (MBBISP) are being accepted now through February 1, 2011.

Monsanto Company (Monsanto), along with its subsidiaries, is a provider of agricultural products for farmers. The Company’s seeds, biotechnology trait products, and herbicides provide farmers with solutions that improve productivity.

************************************

Kimberly-Clark Corporation (NYSE:KMB) announced that net sales in the third quarter of 2010 increased 1.3 percent to $5.0 billion. Organic sales rose 1 percent, driven by higher sales volumes of 1 percent, while net selling prices were even with year-ago levels. The I-Flow Corporation acquisition completed in 2009 added an additional point of sales growth, while changes in foreign currency rates reduced sales by 1 percent.

Kimberly-Clark Corporation is a global health and hygiene company focused on product innovation and building its personal care, consumer tissue, K-C Professional and Other and health care brands.

THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY!

Disclaimer: Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. DrStockPick.com publisher and its affiliates and contractors are not registered investment advisers or broker/dealers. Our disclaimer is to be read and fully understood before using our site, reading our newsletter or joining our email list. Release of Liability: Through use of this website viewing or using, you agree to hold DrStockPick.com report and Crown Equity Holdings Inc. CRWE, its operators, shareholders, employees and/or contractors harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damages (monetary or otherwise) that you may occur. (Read more at http://drstockpick.com/disclaimer) .Rule 17B requires disclosure of payment for investor relations. Crown Equity Holdings, Inc. (CRWE.OB) is a newswire as well as an IR and PR firm. Crown Equity Holdings Inc. (CRWE.OB), in some cases, provides media advertising and public awareness for both public and private companies, as well as disseminating news. As such, in some cases, when Crown Equity Holdings Inc. (CRWE.OB) advertises for a particular client, Crown Equity Holdings Inc. (CRWE.OB) charges an advertising fee which it must disclose under 17B. The fee may be in cash, in free trading stock or in restricted stock. Crown Equity Holdings Inc. (CRWE.OB), if paid in stock, can and may sell those securities during the advertising period. Crown Equity Holdings Inc. (CRWE.OB) has received five thousand dollars and anticipates receiving another forty five thousand dollars in cash from a third party for (thirty) days of advertising for Eline Entertainment Group, Inc. (EEGI.PK)

Crown Equity Holdings Inc. (CRWE.OB) has received 1,000,000 shares 144 restricted stocks for IT department services from Power 3 Medical Products Inc. (PWRM.OB).

Power 3 Medical Products Inc., (OTCBB:PWRM) is a leader in bio-medical research and the commercialization of neurodegenerative disease and cancer biomarkers, pathways, and mechanisms of diseases through the development of diagnostic tests and drug targets.

PWRM’s patent-pending technologies are being used to develop screening and diagnostic tests for the early detection and prognosis of disease, identify protein biomarkers, drug targets, and its diagnostic tests are targeted toward markets with critical unmet needs in areas including neurodegenerative disease (NuroPro) and breast cancer (BC-SeraPro).

PWRM expects to complete phase II clinical validation trials of its blood serum diagnostics for Alzheimer’s disease (NuroPro-AD), Parkinson’s disease (NuroPro-PD) and breast cancer in 2010, followed by filings with the FDA.

** PWRM has signed a definitive agreement to acquire all of the stock of Rozetta-Cell Life Sciences, Inc., a medical biotechnology company that focuses on the delivery and imaging of stem cells during therapy.

PWRM plans to effectuate the acquisition of Rozetta-Cell by merging Rozetta-Cell with and into PWRM, with PWRM remaining as the surviving company in the merger.

Rozetta-Cell is a medical biotechnology company that focuses on the delivery and imaging of stem cells during therapy. The company has a robust intellectual property portfolio and has created numerous products for adult stem cell therapy that are ready for market globally. Rozetta-Cell also has several collaborations in process through which it is partnering with industry-leading adult stem cell research companies and adult stem cell vendors.

The acquisition of Rozetta-Cell is expected to be completed in October or November 2010.

More about PWRM at www.power3medical.com

******************

Keithley Instruments, Inc. (NYSE:KEI), a world leader in advanced electrical test instruments and systems, extends its congratulations to Drs. Andre Geim and Konstantin Novoselov, scientists at the University of Manchester in England who were just awarded the 2010 Nobel Prize in Physics for their research on graphene, a single-atom-thick form of carbon with outstanding physical, electrical, and chemical properties.

In their research, Geim and Novoselov employed several Keithley Instruments products, including the Model 2400 SourceMeter® instrument and the Model 2182A Nanovoltmeter.

******************

Kelly Services, Inc. (NASDAQ:KELYA) (NASDAQ:KELYB), a leader in providing workforce solutions, was named to Inavero’s 2010 Best of Staffing™ Candidate list today. Best of Staffing, presented in partnership with CareerBuilder, is the nation’s only candidate satisfaction award that recognizes top staffing and recruiting firms that provide exceptional service to their employees (i.e., contract, contingent, temporary).

******************

KEMET Corporation (Amex: KEM), a leading manufacturer of tantalum, ceramic, aluminum, film, paper and electrolytic capacitors, is nominated for the European electronics industry’s prestigious Elektra 2010 Product of the Year Award.

KEMET’s base metal electrode class-I high temperature capacitor is a finalist in the Passive and Electromechanical Product of the Year category.

**************************************************************

THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY!

Disclaimer: Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. DrStockPick.com publisher and its affiliates and contractors are not registered investment advisers or broker/dealers. Our disclaimer is to be read and fully understood before using our site, reading our newsletter or joining our email list. Release of Liability: Through use of this website viewing or using, you agree to hold DrStockPick.com report and Crown Equity Holdings Inc. CRWE, its operators, shareholders, employees and/or contractors harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damages (monetary or otherwise) that you may occur. (Read more at http://drstockpick.com/disclaimer) .Rule 17B requires disclosure of payment for investor relations. Crown Equity Holdings, Inc. (CRWE.OB) is a newswire as well as an IR and PR firm. Crown Equity Holdings Inc. (CRWE.OB), in some cases, provides media advertising and public awareness for both public and private companies, as well as disseminating news. As such, in some cases, when Crown Equity Holdings Inc. (CRWE.OB) advertises for a particular client, Crown Equity Holdings Inc. (CRWE.OB) charges an advertising fee which it must disclose under 17B. The fee may be in cash, in free trading stock or in restricted stock. Crown Equity Holdings Inc. (CRWE.OB), if paid in stock, can and may sell those securities during the advertising period. Crown Equity Holdings Inc. (CRWE.OB) has received 1,000,000 shares 144 restricted stocks for IT department services from Power 3 Medical Products Inc. (PWRM.OB).